Pharmaceutical
Medical
Health

Abbott

$75.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.63 (-0.83%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Abbott and other stocks, options, ETFs, and crypto commission-free!

About

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. Read More The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Employees
103,000
Headquarters
Abbott Park, Illinois
Founded
1888
Market Cap
134.54B
Price-Earnings Ratio
51.09
Dividend Yield
1.60
Average Volume
5.95M
High Today
$76.14
Low Today
$75.32
Open Price
$76.14
Volume
1.93M
52 Week High
$80.74
52 Week Low
$60.32

Collections

Pharmaceutical
Medical
Health
Medical Devices
Healthcare
Manufacturing
Technology
US

News

Seeking AlphaMay 21

Abbott's tricuspid valve repair device shows positive effect in study

Results from a study called TRILUMINATE evaluating Abbott's (ABT +0.7% ) minimally invasive tricuspid valve repair system in 85 patients with symptomatic moderate (or greater) tricuspid regurgitation (TR) showed a treatment benefit.

129
Yahoo FinanceMay 13

Abbott Rides on Strong CGM, Poor Rhythm Management Ails

On May 10, we issued an updated research report on Abbott Laboratories ABT. The company has been consistently delivering solid organic growth in the Established Pharmaceuticals (EPD) and Diabetes segments.

254
Yahoo FinanceMay 10

Global Optical Coherence Tomography Industry Outlook to 2023 with Abbott Labs, Canon, Heidelberg Engineering, Nikon Corp, Phoenix Research Labs, Thorlabs, and Topcon Dominating

Dublin, May 10, 2019 (GLOBE NEWSWIRE) -- The "Global Markets and Technologies for Optical Coherence Tomography (OCT)" report has been added to ResearchAndMarkets.

103

Earnings

$0.58
$0.66
$0.73
$0.81
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 17, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.